Start the conversation
Investing in clinical–stage biotech companies can lead to unimaginable profits. In fact, one of these penny stocks from the biotech sector has a chance at 130% growth.
These startups work to change the world with new drugs, therapies, and treatments. If any of them has a breakthrough – such as a new innovation, successful trial, or FDA approval – it could double your money.